SOLICITATION NOTICE
B -- Notice of Intent: Report of Clinical Unity of Treating Patients with compounded BHRT
- Notice Date
- 7/25/2018
- Notice Type
- Synopsis
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- 5630 Fishers Lane, Room 2129 Rockville MD 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-18-NOI-1204160
- Response Due
- 8/9/2018
- Point of Contact
- Christopher R. McGucken, Contract Specialist, Phone (240) 402-7566
- E-Mail Address
-
christopher.mcgucken@fda.hhs.gov
- Small Business Set-Aside
- N/A
- Description
- This synopsis is hereby issued in accordance with FAR Part 5.203 and FAR 6.302 in response to the mandatory requirement for a 15 day notification. The purpose of this synopsis is to announce the Food and Drug Administration's intent to negotiate a Firm Fixed Price sole source order with the National Academies of Science, Engineering, and Medicine (NASEM) located at 500 Fifth Street NW, Washington DC 20001 for a report on the clinical utility of treating patients with compounded bioidentical hormone replacement therapy. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (25-JUL-2018); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-18-NOI-1204160/listing.html)
- Record
- SN05005957-F 20180727/180725230759 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |